v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash Flows From Operating Activities:        
Net loss $ (1,146,096) $ (603,084) $ (5,167,569) $ (3,122,557)
Adjustments to reconcile net loss to net cash used in operating activities:        
Amortization of debt issuance costs and discounts 53,722 53,722 239,789
Change in fair value of derivative liabilities 6,312 6,312 17,087
Gain on extinguishment of debt (326,345) (326,345) 194,537
Stock-based compensation 345,396 496,864
Shares issued in exchange for services     250,000
Changes in operating assets and liabilities:        
Prepaid expenses 88,282 (468,321)    
Accounts payable - trade (140,781) (688,124) 496,910 1,080,744
Accrued expenses 256,901 (268,226) (453,445) 851,311
Accrued interest - related party (4,746)    
Accrued interest 18,936 14,190 101,260
Prepaid expenses and other current assets     (148,531) (11,454)
Net Cash Used In Operating Activities (596,298) (2,279,876) (4,777,892) (649,283)
Cash Flows From Financing Activities:        
Repayment of financing liability (92,407)    
Repayment of notes payable- related party (275,000) (275,000)
Proceeds from issuance of common stock in private placement 652,000    
Proceeds from issuance of common stock and warrants in private placement 6,161,505 7,161,504
Payment of issuance costs related to private placement (121,160) (1,266,485) (1,683,523) (193,876)
Proceeds from issuance of convertible notes payable     1,000,000
Payment of debt issuance costs     (127,510)
Net Cash Provided By Financing Activities 438,433 4,620,020 5,202,981 678,614
Net (Decrease) Increase In Cash and Cash Equivalents (157,865) 2,340,144 425,089 29,331
Cash and Cash Equivalents - Beginning of Period 459,174 34,085 34,085 4,754
Cash and Cash Equivalents - End of Period 301,309 2,374,229 459,174 34,085
Cash paid for:        
Interest 1,943 9,584 9,584
Income taxes
Non-cash investing and financing activities:        
Recapitalization of Unite Acquisition 1 Corp. accumulated deficit at time of the exchange (279,746) (279,746)
Common stock cancelled at the time of the exchange 175 175
Convertible notes and accrued interest converted into common stock 1,653,811 1,653,811
Forgiveness of accrued consulting fees by related parties 345,900 $ 345,900
Accrual of equity issuance costs 16,315    
Financing of Director and Officer insurance policy $ 333,105